• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Technology evaluation: ABX-EGF, Abgenix/Amgen.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Ranson, Malcolm R
    Affiliation
    University of Manchester, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 4BX, UK. malcolm.ranson@man.ac.uk
    Issue Date
    2003-10
    
    Metadata
    Show full item record
    Abstract
    Abgenix and Amgen (formerly Immunex) are developing ABX-EGF, a human monoclonal antibody against the epidermal growth factor receptor, for potential use in the treatment of cancer. ABX-EGF is undergoing phase II trials in patients with renal, colorectal, prostate and non-small-cell lung cancers. By July 2002, phase III trials for these indications were planned to start in 2003.
    Citation
    Technology evaluation: ABX-EGF, Abgenix/Amgen. 2003, 5 (5):541-6 Curr. Opin. Mol. Ther.
    Journal
    Current Opinion in Molecular Therapeutics
    URI
    http://hdl.handle.net/10541/78899
    PubMed ID
    14601524
    Type
    Article
    Language
    en
    ISSN
    1464-8431
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody.
    • Authors: Foon KA, Yang XD, Weiner LM, Belldegrun AS, Figlin RA, Crawford J, Rowinsky EK, Dutcher JP, Vogelzang NJ, Gollub J, Thompson JA, Schwartz G, Bukowski RM, Roskos LK, Schwab GM
    • Issue date: 2004 Mar 1
    • Technology evaluation: bevacizumab, Genentech/Roche.
    • Authors: Salgaller ML
    • Issue date: 2003 Dec
    • Panitumumab the first fully human monoclonal antibody: from the bench to the clinic.
    • Authors: Cohenuram M, Saif MW
    • Issue date: 2007 Jan
    • Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy.
    • Authors: Yang XD, Jia XC, Corvalan JR, Wang P, Davis CG
    • Issue date: 2001 Apr
    • Technology evaluation: Onyvax-105, Onyvax.
    • Authors: Blumenthal RD
    • Issue date: 2003 Dec
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.